Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

ClinicalTrials.gov ID: NCT03441360

Public ClinicalTrials.gov record NCT03441360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Open-label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted as an assessment of the safety and preliminary activity of eribulin mesylate in pediatric participants with relapsed/refractory rhabdomyosarcoma (RMS), non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), or Ewing sarcoma (EWS) to determine whether each cohort warrants further investigation.

Study identification

NCT ID
NCT03441360
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
23 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Months to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 17, 2018 (Actual)
Primary completion
Jan 7, 2021 (Actual)
Completion
Jan 21, 2022 (Actual)
Last update posted
Oct 5, 2022

2018 – 2022

United States locations

U.S. sites
41
U.S. states
27
U.S. cities
39
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Phoenix Children's Hospital Phoenix Arizona 85016 —
Loma Linda University Cancer Center Loma Linda California 92350 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Southern California Permanente Medical Group Los Angeles California 90027 —
Children's Hospital of Orange County Orange California 92868 —
Rady Children's Hospital- San Diego San Diego California 92123 —
Connecticut Children's Medical Center Hartford Connecticut 06106 —
Nemours / A.I. duPont Hospital for Children Wilmington Delaware 19803 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Children's Clinic Jacksonville Florida 32207 —
Children's Healthcare of Atlanta Atlanta Georgia 30322 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Riley Hospital for Children - Indiana University Indianapolis Indiana 46202 —
Blank Children's Hospital Des Moines Iowa 50309 —
Norton Children's Hospital Louisville Kentucky 40202 —
Johns Hopkins University Baltimore Maryland 21287 —
CS Mott Children's Hospital Ann Arbor Michigan 48109 —
Children's Hospitals and Clinics of Minnesota Minneapolis Minnesota 55404 —
University of Minnesota Minneapolis Minnesota 55455 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Children's Mercy Hospital and Clinics Kansas City Missouri 64108 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Rutgers cancer Institute of NJ New Brunswick New Jersey 08853 —
Columbia University Medical Center New York New York 10032 —
Children's Hospital Medical Center of Akron Akron Ohio 44308 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Randall Children's Hospital at Legacy Emanuel Portland Oregon 97227 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Penn State Health Hershey Medical Center Hershey Pennsylvania 17033 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 —
Children's Medical Center Dallas Texas 75235 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229 —
Children's Hosptial of The King's Daughters Norfolk Virginia 23507 —
Seattle Children's Seattle Washington 98105 —
Providence Sacred Heart Medical Center and Children's Hospital Spokane Washington 99204 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03441360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03441360 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →